Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263782 Methods and compositions for treating hiv infection
10/18/2012US20120263764 Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease
10/18/2012US20120263763 Regenerative materials
10/18/2012US20120263759 Coating Comprising An Elastin-Based Copolymer
10/18/2012US20120263748 Superior Molecular Vaccine Linking the Translocation Domain of a Bacterial Toxin to an Antigen
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263745 Antichlamydial agents
10/18/2012US20120263738 Multiplex dicer substrate rna interference molecules having joining sequences
10/18/2012US20120263736 Method for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation
10/18/2012US20120263729 Compositions and methods for treating cardiovascular disease
10/18/2012US20120263714 Substituted halophenoxybenzamide derivatives
10/18/2012US20120263710 Administering anti-placental growth factor antibodies
10/18/2012US20120263709 Use of il-33 antagonists to treat fibrotic diseases
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263703 Coagulation factor ix compositions and methods of making and using same
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263701 Coagulation factor vii compositions and methods of making and using same
10/18/2012US20120263700 Human cystathionine beta-synthase variants and methods of production thereof
10/18/2012US20120263698 Treatment of Neurodegenerative Disease
10/18/2012US20120263688 Rumc peptides with antimicrobial activity
10/18/2012US20120263685 Anti-tumor composition comprising human-derived adult stem cells
10/18/2012US20120263680 Compositions And Methods For Preventing Or Treating Diseases, Conditions, Or Processes Characterized By Aberrant Fibroblast Proliferation And Extracellular Matrix Deposition
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263678 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
10/18/2012US20120263677 Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
10/18/2012US20120263676 Compositions, methods and kits relating to her-2 cleavage
10/18/2012US20120263675 Bivalent diazo bicyclic smac
10/18/2012US20120263674 Pseudomonas exotoxin a with reduced immunogenicity
10/18/2012US20120263673 Compositions and methods for reducing the risk of preeclampsia
10/18/2012US20120263667 Composition and method for modulating and maintaining vaginal bacterial flora and vaginal acidity
10/18/2012US20120263665 Peptide
10/18/2012US20120263663 Compositions and methods for prevention of photoaging
10/18/2012US20120263660 Hair Loss Treatment
10/18/2012US20120263654 Melanoma specific biomarker
10/18/2012DE102011017208A1 Bivalirudin und andere Hirudin-Analoga zur Konservierung der zellulären Funktionalität in der klinischen Zelltherapie Bivalirudin and other hirudin analogues for the preservation of cellular functionality in clinical cell therapy
10/18/2012DE102011016875A1 Zubereitung enthaltend DISC1 und/oder mindestens ein DISC1-Fragment zur Anwendung bei der therapeutischen Behandlung des menschlichen oder tierischen Körpers Preparation comprising DISC1 and / or at least one DISC1 fragment for use in the therapeutic treatment of the human or animal body
10/18/2012CA2833176A1 Chimeric antibacterial polypeptides
10/18/2012CA2833171A1 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9
10/18/2012CA2833158A1 Variants of human gdnf
10/18/2012CA2833078A1 Treatment of microbial infections
10/18/2012CA2833023A1 System and method for multiphasic release of growth factors
10/18/2012CA2832933A1 Methods for treating bacterial infection
10/18/2012CA2832910A1 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
10/18/2012CA2832829A1 Treatment of hepatitis c virus infection with alisporivir
10/18/2012CA2832811A1 Double-acylated glp-1 derivatives
10/18/2012CA2832664A1 Pharmaceutical composition
10/18/2012CA2832521A1 Therapeutic peptides and use thereof against huntington's disease
10/18/2012CA2830689A1 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
10/18/2012CA2827792A1 Pre-operative use of metabolic activation therapy
10/18/2012CA2825119A1 Protein hydrolysate compositions having enhanced cck and glp-1 releasing activity
10/17/2012EP2511298A2 Compositions and Methods for Diagnosing and Treating Cancer
10/17/2012EP2511294A2 Conjugates and compositions for immunotherapy and anti-tumor treatment
10/17/2012EP2510982A1 Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
10/17/2012EP2510956A1 Adipocyte sheet, three-dimensional structure thereof, and method for producing the same
10/17/2012EP2510944A1 Treatment of bacterial infections
10/17/2012EP2510943A1 Methods and compositions related to targeting tumors and wounds
10/17/2012EP2510942A1 Use of natriuretic peptide for treating heart failure
10/17/2012EP2510941A2 Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
10/17/2012EP2510940A1 Use of cyr61 protein for preparing medicine
10/17/2012EP2510939A1 Anti-connexin peptide mimetics and therapeutic uses thereof
10/17/2012EP2510938A1 Anti-connexin antisense compounds and use thereof for treating vascular disorders
10/17/2012EP2510937A1 Anti-connexin compounds and use thereof in combination with transplant or grafting procedures
10/17/2012EP2510936A1 Calcium binding peptides
10/17/2012EP2510935A1 Calcium binding peptides
10/17/2012EP2510934A1 Methods for promoting neurite outgrowth and survival of dopaminergic neurons
10/17/2012EP2510929A1 Methods for treating bacterial infection
10/17/2012EP2510921A1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
10/17/2012EP2510811A2 Use of nutritional compositions for preventing disorders
10/17/2012EP2510358A1 Methods of inhibiting metastatic cancer by administration of streptolysin o
10/17/2012EP2510097A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/17/2012EP2510091A1 Method and composition to increase radiation-induced tumor therapeutic effects
10/17/2012EP2510087A2 Pathogen restriction factors
10/17/2012EP2509997A1 Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
10/17/2012EP2509995A2 Insulin analogues with chlorinated amino acids
10/17/2012EP2509992A2 Treatments for gastrointestinal disorders
10/17/2012EP2509628A2 Sr-bi as a predictor of human female infertility and responsiveness to treatment
10/17/2012EP2509625A1 Aminoacyl trna synthetases for modulating inflammation
10/17/2012EP2509624A1 Enzymatic wound debriding compositions with enhanced enzymatic activity
10/17/2012EP2509623A1 Methods and compositions using peroxiredoxin 1 (prx1) as an adjuvant
10/17/2012EP2509622A2 Inhibiting bacterial infection and biofilm formation
10/17/2012EP2509621A1 Use of transferrin in treatment of beta-thalassemias
10/17/2012EP2509620A2 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
10/17/2012EP2509619A2 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
10/17/2012EP2509618A2 Systemic administration of an agent that permeabilises tumour vasculature
10/17/2012EP2509617A1 Arenicin-3 for use in the treatment of urinary tract infections
10/17/2012EP2509616A1 Bche albumin fusions for the treatment of cocaine abuse
10/17/2012EP2509615A1 Novel cyclic peptides
10/17/2012EP2509614A1 Antimicrobial water treatment membranes and production thereof
10/17/2012EP2509593A2 Therapeutic use of protein-polymer conjugates
10/17/2012EP2509583A2 Pharmaceutical composition comprising oligopeptides, preferably cilengitide
10/17/2012CN1962862B Method for high-density fermentation production of recombinant earthworm fibrinolysin PI239 in yeast system and engineering bacterium therefor
10/17/2012CN1684701B Ophthalmologic irrigation solutions and method
10/17/2012CN102741422A Coagulation factor ix compositions and methods of making and using same
10/17/2012CN102741279A B7-h4 fusion proteins and methods of use thereof
10/17/2012CN102741277A IFN[gamma]inhibitors in the treatment of motoneuron diseases
10/17/2012CN102741276A Synthetic myostatin peptide antagonists
10/17/2012CN102741272A Peptides inhibiting adhesion of aspergillus fumigatus to cornea
10/17/2012CN102741270A Cyclic peptide inhibitors of hepatitis c virus replication
10/17/2012CN102740894A Sdf-1 delivery for treating ischemic tissue
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 3163